Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stedman

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogsVirginia Haurigot, Federico Mingozzi, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Nature Communications|January 16, 2026
Optimal murine CD4<sup>+</sup> T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processingJulia E Rood, Suh Kyung Yoon, Mary K Heard, et al.
Nature Medicine|April 15, 1999
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorJ P Greelish, L T Su, E B Lankford, et al.
Gene Therapy|January 14, 2011
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivoJ D White, D M Thesier, J B D Swain, et al.
Science (New York, N.Y.)|January 23, 1987
Thunderstorms: an important mechanism in the transport of air pollutantsR R Dickerson, G J Huffman, W T Luke, et al.
Nature Medicine|October 9, 2019
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal modelsYafeng Song, Leon Morales, Alock S Malik, et al.
Journal of Neuropathology and Experimental Neurology|October 6, 2006
Limb-girdle muscular dystrophy in the United StatesSteven A Moore, Christopher J Shilling, Steven Westra, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogsVirginia Haurigot, Federico Mingozzi, George Buchlis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Nature Communications|January 16, 2026
Optimal murine CD4<sup>+</sup> T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processingJulia E Rood, Suh Kyung Yoon, Mary K Heard, et al.
Nature Medicine|April 15, 1999
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorJ P Greelish, L T Su, E B Lankford, et al.
Gene Therapy|January 14, 2011
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivoJ D White, D M Thesier, J B D Swain, et al.
Science (New York, N.Y.)|January 23, 1987
Thunderstorms: an important mechanism in the transport of air pollutantsR R Dickerson, G J Huffman, W T Luke, et al.
Nature Medicine|October 9, 2019
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal modelsYafeng Song, Leon Morales, Alock S Malik, et al.
Journal of Neuropathology and Experimental Neurology|October 6, 2006
Limb-girdle muscular dystrophy in the United StatesSteven A Moore, Christopher J Shilling, Steven Westra, et al.
Pageof 11